Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Supratentorial Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Postoperative Hemorrhage 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Hodgkin Disease 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Anus Neoplasms 1Agnosia 1

Interventions

Bupivacaine 4Saline Solution 3Ketamine 3Transcutaneous Electric Nerve Stimulation 2Ropivacaine 2Radiofrequency Ablation 2Magnesium Sulfate 2Ketorolac 2Dexmedetomidine 2Control Groups 2Anesthesia, Local 2Acupuncture Therapy 2Acetaminophen 2engage 8200 1Yoga 1Varenicline 1Transdermal Patch 1Therapeutics 1Telemedicine 1Surgical Instruments 1STAMP-I protocol 1Radiosurgery 1Psilocybin 1Palliative Care 1Oxycodone 1Music Therapy 1Morphine 1Methods 1Levobupivacaine 1Ketoprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Agnosia × Epinephrine × 1 year × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡